Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)(NKE)
植込み型心臓再同期機能付きペースメーカパルスジェネレータ(CRT-P) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。
28 件
直近 2026.05.06
0 件
649 件
14,494 件
分類情報
| Product Code | NKE |
|---|---|
| デバイス名 | Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P) 植込み型心臓再同期機能付きペースメーカパルスジェネレータ(CRT-P) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。 |
| デバイスクラス | クラス III |
| 21 CFR 規制番号 | - |
| 審査区分 | PMA(市販前承認) |
| 医療専門分野 | Unknown |
| 定義 | These devices are indicated for patients who have moderate to severe heart failure. These new devices use an additional lead to provide synchronized pacing of the heart, in addition to the regular features of a pacemaker. These products are sought for the treatment of patients who have moderate to severe heart failure. これらの機器は、中等度から重度の心不全を有する患者を対象としている。これらの新しい機器は、ペースメーカの通常の機能に加えて、追加のリードを用いて心臓の同期的なペーシングを行う。これらの製品は、中等度から重度の心不全を有する患者の治療のために求められている。 この日本語訳は AI が生成した参考訳です。正確な内容は英語の原文をご確認ください。 |
| フラグ | インプラント機器 生命維持機器 |
| AI分析 | 本品は米国FDAの規制上クラスIIIに分類されており、市販前承認(PMA)による審査を受ける必要があります。クラスIIIは人の生命維持や健康に重大な影響を及ぼすおそれのある機器に適用される最も厳格な規制区分であり、有効性と安全性を示す科学的根拠を伴う詳細な審査が求められます。 米国市場での動向 本製品はPMA区分で、本承認3件・一部変更承認約650件が累計されており、直近では2026年7月にも判定が行われています。不具合報告は累計約14,300件で、そのうち死亡272件、傷害が約7,800件と、大半が死亡・傷害の報告で占められており、主な問題としてはバッテリーの早期消耗(Premature Discharge of Battery)、不正確・不適切な結果や読み取り(Incorrect, Inadequate or Imprecise Result or Readings)、オーバーセンシング(Over-Sensing)が挙げられています。回収は累計28件で、うちクラスI(最重篤)が11件、クラスIIが16件含まれ、直近5年間では8件、最新の回収は2026年3月に開始されています。 この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。 |
類似の国内医療機器(自動推定)
FDA デバイス分類と JMDN 英語名の名称・定義文の類似度から機械的に推定した候補です。日米の当局が定めた公的な対応関係ではなく、参考情報としてご覧ください。
| No. | 類別 | 一般的名称 | 品目数 | 企業数 | 年間総出荷額 | 成長率 | 平均価格 | 国産比率 |
|---|---|---|---|---|---|---|---|---|
| 1 | 内臓機能代用器 | 植込み型心臓ペースメーカクラスⅣ | 45 | 9 | 222.5 億円/年 | -0.8% | 42.55 万円/個 | 0.0% |
| 2 | 内臓機能代用器 | 除細動機能付植込み型両心室ペーシングパルスジェネレータクラスⅣ | 41 | 8 | 137.3 億円/年 | -29.5% | 180.66 万円/個 | 0.0% |
| 3 | 内臓機能代用器 | 除細動機能なし植込み型両心室ペーシングパルスジェネレータクラスⅣ | 24 | 8 | 25 億円/年 | -20.5% | 128.23 万円/個 | 0.0% |
| 4 | 内臓機能代用器 | 植込み型リードレス心臓ペースメーカクラスⅣ | 5 | 2 | — | — | — | — |
| 5 | 内臓機能代用器 | 植込み型両心室同期ペースメーカクラスⅣ | — | — | — | — | — | — |
FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。
米国での回収・承認・不具合報告
米国回収
全 28 件| 回収番号 | クラス | 回収開始日 | 企業 | 理由 | ステータス |
|---|---|---|---|---|---|
| Z-1771-2026 NKE | クラス I(最重篤) | 2026.03.19 | Boston Scientific Corporation | Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are specifically indicated for treatment of the following: " Conduction disorders that require restoration of AV synchrony, including varying degrees of AV block " VVI intolerance (i.e., pacemaker syndrome) in the presence of persistent sinus rhythm " Low cardiac output or congestive heart failure secondary to bradycardia | 対応中 |
| Z-0105-2026 NKE | クラス I(最重篤) | 2025.08.20 | Boston Scientific Corporation | Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps). | 対応中 |
| Z-0104-2026 NKE | クラス I(最重篤) | 2025.08.20 | Boston Scientific Corporation | Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps). | 対応中 |
| Z-0103-2026 NKE | クラス I(最重篤) | 2025.08.20 | Boston Scientific Corporation | Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps). | 対応中 |
| Z-0102-2026 NKE | クラス I(最重篤) | 2025.08.20 | Boston Scientific Corporation | Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps). | 対応中 |
| Z-0101-2026 NKE | クラス I(最重篤) | 2025.08.20 | Boston Scientific Corporation | Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps). | 対応中 |
| Z-0827-2025 NKE | クラス I(最重篤) | 2024.12.12 | Boston Scientific Corporation | A subset of devices from the ACCOLADE Family of Pacemakers and CRT-Ps, built before September 2018, have an increased potential to initiate Safety Mode during telemetry or other normal, higher-power operations due to latent high battery impedance. | 対応中 |
| Z-0826-2025 NKE | クラス I(最重篤) | 2024.12.12 | Boston Scientific Corporation | A subset of devices from the ACCOLADE Family of Pacemakers and CRT-Ps, built before September 2018, have an increased potential to initiate Safety Mode during telemetry or other normal, higher-power operations due to latent high battery impedance. | 対応中 |
| Z-2020-2021 NKE | クラス I(最重篤) | 2021.06.03 | Boston Scientific Corporation | The dual chamber INGENIO family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) may initiate Safety Mode later in device life (i.e., prior to reaching the Explant battery indicator) when the device's battery exhibits high internal impedance. This latent battery condition puts a device at risk for system resets to occur due to temporary high-power consumption related to telemetry attempts and subsequent reversion to Safety Mode to maintain back-up pacing. Although therapy is still provided when a device is in Safety Mode, replacement is required. - Only dual chamber INGENIO family pacemakers and CRT-Ps built with the Extended Life (EL) battery are included within this advisory population | 対応中 |
| Z-2019-2021 NKE | クラス I(最重篤) | 2021.06.03 | Boston Scientific Corporation | The dual chamber INGENIO family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) may initiate Safety Mode later in device life (i.e., prior to reaching the Explant battery indicator) when the device's battery exhibits high internal impedance. This latent battery condition puts a device at risk for system resets to occur due to temporary high-power consumption related to telemetry attempts and subsequent reversion to Safety Mode to maintain back-up pacing. Although therapy is still provided when a device is in Safety Mode, replacement is required. - Only dual chamber INGENIO family pacemakers and CRT-Ps built with the Extended Life (EL) battery are included within this advisory population | 対応中 |
| Z-2018-2021 NKE | クラス I(最重篤) | 2021.06.03 | Boston Scientific Corporation | The dual chamber INGENIO family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) may initiate Safety Mode later in device life (i.e., prior to reaching the Explant battery indicator) when the device's battery exhibits high internal impedance. This latent battery condition puts a device at risk for system resets to occur due to temporary high-power consumption related to telemetry attempts and subsequent reversion to Safety Mode to maintain back-up pacing. Although therapy is still provided when a device is in Safety Mode, replacement is required. - Only dual chamber INGENIO family pacemakers and CRT-Ps built with the Extended Life (EL) battery are included within this advisory population | 対応中 |
| Z-2003-2021 NKE | クラス II | 2021.06.03 | Boston Scientific Corporation | Latent release of small amounts of hydrogen within the pacemaker may cause a low voltage capacitor to become electrically compromised over time resulting in accelerated battery depletion of the battery and associated progression of displayed battery depletion indicators. | 対応中 |
| Z-2002-2021 NKE | クラス II | 2021.06.03 | Boston Scientific Corporation | Latent release of small amounts of hydrogen within the pacemaker may cause a low voltage capacitor to become electrically compromised over time resulting in accelerated battery depletion of the battery and associated progression of displayed battery depletion indicators. | 対応中 |
| Z-1523-2021 NKE | クラス II | 2021.04.06 | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) | There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT). | 対応中 |
| Z-2415-2018 NKE | クラス II | 2018.06.21 | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) | Potential for a device reset to occur in Percepta CRT-P MRI SureScan and Percepta Quad CRT-P MRI SureScan due to a timing interaction between the EffectivCRT Diagnostic and the Ventricular Safety Pacing feature (VSP). | 終了 |
| Z-2414-2018 NKE | クラス II | 2018.06.21 | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) | Potential for a device reset to occur in Percepta CRT-P MRI SureScan and Percepta Quad CRT-P MRI SureScan due to a timing interaction between the EffectivCRT Diagnostic and the Ventricular Safety Pacing feature (VSP). | 終了 |
| Z-2413-2018 NKE | クラス II | 2018.06.21 | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) | Potential for a device reset to occur in Percepta CRT-P MRI SureScan and Percepta Quad CRT-P MRI SureScan due to a timing interaction between the EffectivCRT Diagnostic and the Ventricular Safety Pacing feature (VSP). | 終了 |
| Z-2412-2018 NKE | クラス II | 2018.06.21 | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) | Potential for a device reset to occur in Percepta CRT-P MRI SureScan and Percepta Quad CRT-P MRI SureScan due to a timing interaction between the EffectivCRT Diagnostic and the Ventricular Safety Pacing feature (VSP). | 終了 |
| Z-0366-2018 NKE | クラス II | 2017.12.07 | Boston Scientific Corporation | Boston Scientific has received reports of intermittent over-sensing of the Minute Ventilation (MV) sensor signal with certain Boston Scientific pacemaker and cardiac resynchronization therapy pacemaker systems (pacemakers). | 対応中 |
| Z-0365-2018 NKE | クラス II | 2017.12.07 | Boston Scientific Corporation | Boston Scientific has received reports of intermittent over-sensing of the Minute Ventilation (MV) sensor signal with certain Boston Scientific pacemaker and cardiac resynchronization therapy pacemaker systems (pacemakers). | 対応中 |
510(k)(市販前届出)
この product code の 510(k) 情報はありません。
出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認
PMA(市販前承認)
全 649 件| PMA 番号 | 販売名 | 申請者 | 決定日 |
|---|---|---|---|
| P030005/S255 | VALITUDE CRT-P IS1 EL (U125); VALITUDE CRT-P IS4 EL (U128); VISIONIST CRT-P IS1 EL (U225); VISIONIST CRT-P LV1 EL (U | Guidant Corp. | 2026.07.23 |
| P030035/S211 | Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps | ABBOTT MEDICAL | 2026.07.21 |
| P030005/S253 | INVIVE, INTUA, VISIONIST, VALITUDE | Guidant Corp. | 2026.07.01 |
| P030005/S254 | VALITUDE, VALITUDE X4, VISIONIST, VISIONIST X4 | Guidant Corp. | 2026.06.03 |
| P070008/S178 | Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T, Amvia Sky HF-T, Amvia Sky | Biotronik, Inc. | 2026.05.07 |
| P070008/S175 | Renamic Neo | Biotronik, Inc. | 2026.04.24 |
| P030035/S212 | Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps | ABBOTT MEDICAL | 2026.04.24 |
| P030005/S252 | CONTAK RENEWAL MODELS H125 AND H120 WITH THE MODEL 2865 VERSION 1.8 APPLICATION SOFTWARE | Guidant Corp. | 2026.04.01 |
| P070008/S176 | Edora 8 HF-T QP (407137); Edora 8 HF-T (407138); Evity 8 HF-T QP (407139); Evity 8 HF-T (407140); Enitra 8 HF-T QP (4071 | Biotronik, Inc. | 2026.03.05 |
| P070008/S174 | STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD | Biotronik, Inc. | 2026.02.03 |
| P030005/S247 | Accolade CRT Pacemakers (CRT-Ps): VALITUDE CRT-P U125; VALITUDE X4 CRT-P Model U128; VISIONIST CRT-P Models U225, U226 | Guidant Corp. | 2026.01.08 |
| P030005/S250 | VALITUDE (Model U125) VALITUDE X4 (Model U128) VISIONIST (Models U225, U226) VISIONIST X4 (Model U228) Firmware Vers | Guidant Corp. | 2025.12.19 |
| P030005/S251 | VALITUDE (Model U125); VALITUDE X4 (Model U128); VISIONIST (Models U225, U226); VISIONIST X4 (Model U228) | Guidant Corp. | 2025.12.17 |
| P070008/S173 | Sentus ProMRI OTW QP S-75; Sentus ProMRI OTW QP S-85; Sentus ProMRI OTW QP S-95; Sentus ProMRI OTW QP L-75; Sentus ProMR | Biotronik, Inc. | 2025.12.10 |
| P070008/S167 | Edora 8 HF-T QP; Edora 8 HF-T; Evity 8 HF-T QP; Evity 8 HF-T; Enitra 8 HF-T QP; Enitra 8 HF-T; Enticos 8 HF-T QP; Entico | Biotronik, Inc. | 2025.10.24 |
| P030005/S249 | U125 VALITUDE CRT-P,U128 VALITUDE X4 CRT-P,U225 VISIONIST CRT-P,U226 VISIONIST CRT-P,U228 VISIONIST X4 CRT-P | Guidant Corp. | 2025.10.22 |
| P070008/S171 | Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H | Biotronik, Inc. | 2025.10.16 |
| P030005/S248 | Accolade Cardiac Resynchronization Therapy Pacemakers, VALITUDE (Model U125); VALITUDE X4 (Model U128); VISIONIST (Model | Guidant Corp. | 2025.09.22 |
| P070008/S170 | Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr | Biotronik, Inc. | 2025.09.15 |
| P070008/S169 | Edora 8 HF-T QP (407137); Edora 8 HF-T (407138); Evity 8 HF-T QP (407139); Evity 8 HF-T (407140); Enitra 8 HF-T QP (4071 | Biotronik, Inc. | 2025.09.11 |
不具合報告(MAUDE)トレンド
米国不具合報告検索で詳しく見る出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。
出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
取得日: 2026.09.07
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。